Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.36 - $9.25 $7,916 - $203,416
21,991 New
21,991 $8,000
Q1 2022

May 16, 2022

SELL
$0.52 - $1.3 $7,470 - $18,677
-14,367 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$0.66 - $1.18 $9,482 - $16,953
14,367 New
14,367 $9,000
Q3 2020

Nov 16, 2020

SELL
$1.86 - $3.15 $20,028 - $33,919
-10,768 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$2.53 - $4.08 $27,243 - $43,933
10,768 New
10,768 $28,000

Others Institutions Holding HOTH

About Hoth Therapeutics, Inc.


  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.02M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.